Skip to main content
Daniel Link, MD, Oncology, Saint Louis, MO

DanielCLinkMD

Oncology Saint Louis, MO

Deputy Director of Siteman Cancer Center and Chief of the Division of Oncology in the Department of Medicine at Washington University School of Medicine in St. Louis

Dr. Link is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Link's full profile

Already have an account?

  • Office

    1 Barnes Jewish Hospital Plz
    # Div
    Saint Louis, MO 63110
    Phone+1 314-362-8771
    Fax+1 314-362-9333

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1988 - 1989
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1985 - 1988
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1985
  • University of Wisconsin-Milwaukee
    University of Wisconsin-MilwaukeeB.S., 1981

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1988 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Alumni Faculty Acheivement Award Washington University, 2015
  • Elected Member American Association of Physicians, 2009
  • Distinguished Faculty Award for Graduate Student Teaching Washington University, 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Age-realted mtuations associated with clonal hematopoietic expansion and malignancies  
    Xie M. Lu C, Wang J. McLellan MD, Johnson KF, Wendl MC, McMichael JF, Schmidt HK, Yellapantula V, Miller CA, Ozenberger BA, Welch JS, Link DC, Walter MK, Mardis ER, Di..., Nat Med, 10/1/2014
  • Regulation of hematopoietic stem cells by bone marrow stromal cells  
    Anthony BA, and Link DC, Trends in immunology, 1/1/2014
  • Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing  
    Hughes AEO, Magrini V, Demeter R, Miller CA, Fulton R, Fulton LL, Eades WC, Elliot K, Hath S, Westervelt P, Ding L, Conrad DF, White BS, Shao J, Link DC, DiPersio JF, ..., Plos Genetics, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • TGF-_ Signaling Contributes to Myelofibrosis and Clonal Dominance of Myeloproliferative Neoplasms
    Daniel C. Link, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • CXCR4 Inhibition with BL-8040 in Combination with Nelarabine in Patients with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia / Lymphoblastic Lymphoma
    Daniel C. Link, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • CXCR4 Blockade By BL-8040 in T Cell Acute Lymphoblastic Leukemia Decreases Mitochondrial Mass and Induces Non-Apoptotic Cell Death
    Daniel C. Link, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • New concepts in stem cell activity regulation. Invited Speaker 
    Denver, CO - 1/1/2013
  • Chemokine Regulation of Neutrophil Trafficking. Invited Speaker 
    New Orleans, LA - 1/1/2013
  • Genomics of AML (Invited Speaker) 
    San Francisco, CA - 1/1/2012
  • Join now to see all

Press Mentions

  • Link Named Oncology Division Director
    Link Named Oncology Division DirectorMarch 29th, 2023
  • $5 Million Grant Endows Research to Advance Blood Disorder Therapies
    $5 Million Grant Endows Research to Advance Blood Disorder TherapiesSeptember 11th, 2019
  • $11.5 Million Supports Innovation in Leukemia Research
    $11.5 Million Supports Innovation in Leukemia ResearchNovember 6th, 2018
  • Join now to see all

Grant Support

  • Role Of The G-CSF Receptor In Progenitor MobilizationNational Heart, Lung, And Blood Institute2011–2012
  • Clonal Dominance Of Hematopoietic Stem Cells Expressing Mutant CSF3RNational Cancer Institute2009–2012
  • Hematopoietic Developmental MalignancyNational Cancer Institute2010–2011
  • Mutational Profiling Of Mirnas In AMLNational Cancer Institute2009–2010
  • Molecular Pathogenesis Of Severe Congential NeutropeniaNational Heart, Lung, And Blood Institute2004–2008
  • G-CSF Receptor In Progenitor MobilizationNational Heart, Lung, And Blood Institute2004–2008
  • Stem Cell Mobilization To Enhance Tissue RegenerationNational Heart, Lung, And Blood Institute2003–2006
  • G-CSF Receptor And Progenitor MobilizationNational Heart, Lung, And Blood Institute2003
  • G-CSF Receptor And Progenitor MobilizationNational Heart, Lung, And Blood Institute1999–2002
  • C-FGR Gene Regulation In Normal And Leukemic Blood CellsNational Heart, Lung, And Blood Institute1994–1996
  • C-FGR Gene Regulation In Normal And Leukemic Blood CellsNational Heart, Lung, And Blood Institute1992–1993